Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556
Cancer Therapies02:49

Cancer Therapies

7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Foreign Body-induced Pancreatitis-Multimodal Imaging and Multispecialty Collaboration: A Case Report.

Clinical practice and cases in emergency medicine·2026
Same author

Research on RARs in neurodegenerative diseases: A bibliometric analysis.

Medicine·2026
Same author

Esophageal cancer recurrence after multimodality therapy: analysis of patterns and implications on long-term survival.

Journal of thoracic disease·2026
Same author

Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: A Real-World Analysis From Jordan.

JCO global oncology·2026
Same author

2000 Peripheral Pulmonary Lesions Sampled by Shape-Sensing Robotic-Assisted Bronchoscopy and Mobile Cone-Beam Computed Tomography: The Mayo Clinic Experience.

Mayo Clinic proceedings·2026
Same author

[68Ga]Ga-FAPI Surpasses [18F]FDG in Pancreatic Adenosquamous Carcinoma Restaging.

Clinical nuclear medicine·2026

相关实验视频

Updated: Jul 19, 2025

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

562

局部发达的胸腺瘤;新辅助化疗是否有所不同?

Riad Abdel Jalil1, Farah A Abdallah2, Zeinab Obeid2

  • 1Department of Thoracic Oncology, King Hussein Cancer Center, Queen Rania Al Abdullah Street, P.O. Box 1269, Amman, 11941, Jordan. Da.06648@khcc.jo.

Journal of cardiothoracic surgery
|August 17, 2023
PubMed
概括

针对局部晚期胸腺瘤的新辅助化疗 (NACT) 显示了极小的放射和病理效应. 与前期手术相比,这种方法并没有显著改善瘤结果,而NACT组的复发风险更高.

关键词:
组织病理学影响 组织病理学影响新辅助化学疗法新辅助化学疗法射线图形效应 射线图形效应 射线图形效应胸腺瘤是什么意思 胸腺瘤是什么意思

更多相关视频

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

501
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.2K

相关实验视频

Last Updated: Jul 19, 2025

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

562
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

501
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.2K

科学领域:

  • 在瘤学瘤学.
  • 胸部外科手术 胸部外科手术
  • 癌症研究 癌症研究

背景情况:

  • 胸腺瘤是最常见的前中的原发性瘤.
  • 手术切除 (胸膜切除术) 是胸膜瘤的主要治疗方法.
  • 新辅助化疗 (NACT) 被认为是局部晚期或边界切除性胸腺瘤,以提高R0切除率.

研究的目的:

  • 评估新辅助化疗 (NACT) 在局部晚期胸腺瘤的疗效和安全性.
  • 用放射学和病理学标准评估NACT对瘤负担的影响.
  • 为了比较接受NACT和接受前期手术的患者之间的瘤结果.

主要方法:

  • 在2015-2021年期间治疗的23名胸腺瘤患者的回顾性分析.
  • 使用CT扫描和RECIST标准评估瘤负担.
  • 通过测量瘤死的百分比来评估病理反应.

主要成果:

  • NACT对瘤负担的影响很小 (8/12名患者的RECIST稳定疾病).
  • 平均瘤缩率为39.5%,瘤体积没有显著变化.
  • 与前期手术相比,NACT组的复发率更高 (33.3%) 和平均存活时间更短 (43.8个月).

结论:

  • 与前期手术相比,NACT并没有显著改善局部晚期胸腺瘤的瘤结果.
  • 放射学和病理学评估表明,NACT的益处很小.
  • 建议进行多中心研究,以进一步澄清诱导化疗的作用.